Theolytics is a biotechnology company harnessing viruses to combat cancer.
A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population.
In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
Company Details
- Employees
- 27
- Founded
- -
- Address
- Oxford, England Ox4 4dq, Gb
- he****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- theolytics.com
- HQ
- Oxford, England
Theolytics Questions
Theolytics's website is theolytics.com
Theolytics's LinkedIn profile is https://uk.linkedin.com/company/theolytics
Theolytics has
27 employees.
View email and phone details for 27
employees at Theolytics.
Theolytics's industry is
Biotechnology Research
Theolytics's top competitors are
Adaptimmune,
Immunocore,
T-Cypher Bio,
Evox Therapeutics Ltd,
Omass Therapeutics,
Enara Bio,
Pathios Therapeutics,
Sitryx,
Outrun Therapeutics,
Nucleome Therapeutics.
Theolytics's support email address is hello@theolytics.com
Theolytics's categories are Biotechnology Research
Theolytics's founding year is 2017
